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Summary
Self-tolerance is achieved in part through intrathymic deletion of self-reactive T cells. The necessity
of the thymus for this process is suggested by the development ofautoimmune diseases in neonatally
thymectomized (neoTx) mice and by the failure ofclonal deletion in nude mice. Indeed, the present
study demonstrates that neonatal thymectomy on day 3 after birth results in the failure of clonal
deletion of Va11+ T cells in BALB/c mice and VS5+ and V06+ T cells in DBA/2 mice.
However, these potentially autoreactive cells are nonfunctional as measured by proliferation and
lymphokine production after stimulation with appropriate antiV,13 mAbs or stimulator cells.
It appears that this induction of nonresponsiveness may have occurred extrathymically: the early
neonatal thymus (presumably the source of the peripheral T cells observed in neoTx mice) also
contains T cellswith self-reactive receptors, but these cells are fullyfunctional. Therefore, neonatal
thymectomy aborts deletion ofself-reactive T cells, but self-tolerance is maintained through functional
inactivation of potentially self-reactive clones.
T
he immune system must be prepared to mount a response
against foreign antigens while at the same time fail to
generate destructive responses against self-antigens. Three the-
oriesby which T cell tolerance to self-antigens may be main-
tained have been postulated: clonal deletion, direct clonal
inactivation (anergy), and indirect clonal inactivation via
regulatory (suppressor) cells. Acquisition of T cell tolerance
by clonal deletion has in fact beendemonstrated. T cellswith
specificity for certain MHC-encoded antigens plus unidentified
peptides, minor lymphocyte stimulatory (Mls)l antigens rec-
ognized in the context of class II MHC, and male H-Y an-
tigens in the context of class I MHC are deleted during in-
trathymic maturation (1-6) . Therefore, these potentially
self-reactive T cells never reach the periphery. Under condi-
tions in which clonal deletion is inefficient, a second mecha-
nism is utilized to maintain T cell tolerance: self-reactive T
cell clones specific for class II or class 11-associated Mls an-
tigens can be rendered nonresponsive, although the mecha-
nism(s) by which this anergy is achieved is not fully under-
stood (7-11) . Such potentially self-reactive cellswill therefore
not respond to self-antigens, despite escaping deletion in the
thymus. The finalmechanism by which T cell tolerance could
theoretically be achieved is by active suppression of the func-
t Abbreviations used in this paper: Mls, minor lymphocyte stimulatory;
neoTx, neonatally thymectomized.
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tion of autoreactive cells through suppressor or regulatory
cells; to what extent this third alternative operates to impede
harmful self-reactivity is not clear.
It was demonstrated recently that functional lack or removal
of a thymus can, in two different systems, result in impaired
clonal deletion. Athymic nude mice, which lack a functional
thymus, fail to delete T cell clones with potentially self-reactive
TCRs (12, 13). Despite the presence of these "forbidden"
clones in the periphery, athymic miceremain relatively healthy
and do not develop autoimmune diseases. In neonatally
thymectomized (neoTx) mice, T cell clones with potentially
self-reactive antigenic specificity can also be seen to escape
to the periphery (14). Unlike nude mice, however, many strains
of neoTx mice develop a multitude of autoimmune diseases,
suggesting a causative link between the escaped self-reactive
T cell clones and the observed autoimmune phenomenon
(15, 16).
We tested this hypothesis by examining the effect of neo-
natal thymectomy on the development of a spectrum of T
cell specificities in several mouse strains and by analyzing the
functional reactivity of potentially autoreactive cells that es-
capedclonal deletion. We demonstrate that thymectomy can
indeed result in a failure to delete certain "forbidden" T cell
clones. More importantly, this failure to delete T cells with
possible autoreactive TCRs occurs not only in mouse strains
that develop autoimmune diseases upon neonatal thymectomy,
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1277-1285but also in strains of mice not susceptible to autoimmune
diseases, thus questioning the relationship between the failed
clonal deletion and autoimmune disease. Finally, the "for-
bidden" T cell clones that did escape to the periphery in neoTx
mice do not appear to be functional. T cell tolerance appears
to be maintainedby clonal anergy through a mechanism that
cannot be restored by the addition of IL,2. Taken together,
these findings demonstrate that, while clonal deletion may
be dependent on the presence of a thymus, maintenance of
clonal anergy is not. When the absence of a thymus results
in a failure of the clonal deletion process, tolerance is neverthe-
less induced by a mechanism of clonal anergy.
Materials and Methods
Mice.
￿
Timed pregnant BALB/c, DBA/2, and C57B1/6 mice
were obtained from the National Cancer Institute (Frederick, MD).
Thymectomy.
￿
1-8-d-old pups were anesthetized by cooling and
thymectomized according to the method of Sjodin et al. (17).
Enrichmentfor T Lymphocytes.
￿
LNs and spleens were removed
from mice and dissociated into single cell suspensions. RBC were
removed from the spleen cell suspensions by lysis with ammonium
chloride followed by washing with PBS. Cells were incubated with
the appropriate anti-class II antibody (MKD6 [reference 18] and
14-4-4 [reference 19] for H-2d strains; Y3P [reference 20] for H-2°
strains) for 30 min on ice, washed, resuspended in complement
(Accurate Chemical & Scientific Corp., Westbury NY), and in-
cubated at 37°C for 30 min. Dead cells were removed by centrifu-
gation on Lympholyte M (Cedarlane Laboratories).
Flow Cytometry Analysis. Cells were suspended in HBSS
(without phenol red) containing 1% BSA and 0.1% sodium azide.
Cells (106/100 td buffer) were incubated on ice with 10 td of the
appropriate FITC-conjugated antibody. After washing, cells were
stained with biotinylated mAb to CD4, and then allophycocyanin-
labeled avidin (Caltag, So. San Francisco, CA). Control staining
of cells with irrelevant antibody was used to obtain background
fluorescence values.The samples were analyzed on a FACS 440 (B=D
Automated Immunochemistry Becton Dickinson & Co., Moun-
tain View, CA) interfaced to a PDP 11/24 computer (Digital Elec-
tronics, Corp., Maynard, MA). Data were collected on 50,000 cells
and are shown as contour diagrams, with a three-decade log scale
of green fluorescence on the x-axis and a three-decade log scale
ofred fluorescence on the y-axis. Reagents used for direct staining
were FITC- or biotin-conjugated anti-: pan TCRa/0 (21), Vli3
(22), V05.1, 5.2 (5), V06 (23), V08.1, 8.2 (24, 25), V08.2 (26),
V011 (4), V014 (27), and CD4 (28).
T Cell Proliferation Assays.
￿
For mAb-induced proliferation, the
purified mAb was diluted to the indicated concentration in PBS
and 30 gl was added per round-bottom microtiterwell. Plates were
incubated for 2-3 h at 37°C and then washed three times with
PBS before use. 2 x 105 T cell-enriched spleen cells in 200 jA1
complete DMEM (10% FCS, 5 x 10'5 M 2-ME, 10 mM Hepes,
200 mM glutamine, 0.11 mg/ml sodium pyruvate, 10 U/ml peni-
cillin, and 100lAg/ml streptomycin) were added per well. rIL2 was
added where indicated at a final concentration of 10 U/ml. After
48 h, cultures were pulsed with 1 p,Ci of [3H]thymidine and har-
vested 12-18 h later. Values represent the arithmetic mean of tripli-
cate cultures. SEs were generally <10% of the mean.
For mixed lymphocyte cultures, the indicated number of T
cell-enriched spleen cells was incubated with 5 x 105 irradiated
(2,000 rad) spleen cells in 96-well flat-bottom microtiter plates. After
3 d, cultures were pulsed with 1 p,Ci of [3H]thymidine and har-
1278
￿
Neonatal Thymectomy and Tolerance
vested 12-18 h later. All determinations were performed in tripli-
cate. Data are expressed as Acpm (cpm values ofexperimental groups
minus responder cells alone).
Lymphokine Assay.
￿
After 48 h of culture, 100 pl of superna-
tant harvested from mAb stimulation assays were incubated with
5 x 103 CTLL2 cells in flat-bottomed microtiter plates. Cultures
were incubated for 36 h and then pulsed with i ACi of [3H]thymi-
dine and harvested 8 h later. Data are expressed as Acpm (cpm values
of experimental supernatants minus cpm values of unstimulated
supernatants). Values represent the arithmetic mean of triplicate
cultures. SEs were <10% of the mean.
Results
Neonatal Thymectomy Results in Escape ofSome T Cellsfrom
Deletion. Development ofmAbs with specificity for the V0
chain of the T cell receptor has enhanced the ability to ana-
lyze objectively the development of the T cell repertoire, in
that it replaced complex functional procedures to determine
TCR specificities with flow cytometry analysis. In the BALB/c
strain ofmice, the repertoire is negatively affected by the ex-
pression of I-Ed, which results in intrathymic deletion of
V05 and (if other so-called "co-tolerogens" are present as
well [reference 5]) V011-expressing T cells, and by the ex-
pression of Mls-2a, which removes T cells with V#3 from
the repertoire. The DBA/2 strain is also affected by expres-
sion ofMls-1a, which results in deletion ofV/36- and Vf8.1-
expressing T cells, in addition to the deletions found in
BALB/c.
To examine whether clonal deletion of these particular T
cell clones is dependent on the presence of a thymus, we
thymectomized mice on day 3 after birth and analyzed the
peripheral T cell repertoire 2-4 mo later. Two-color flow
cytometry analysis of VO expression vs. CD4 was performed
on T cell-enriched lymph node cells (Fig. 1) as well as spleen
cells (data not shown). The resulting data were normalized
for the number of TCR-cx/a+ T cells (Table 1) . As shown
in Table 1, the percentage of V011+ cells is significantly in-
creased in thymectomized BALB/c mice as compared to sham-
thymectomized littermates. In addition, V06+ T cells also
escape deletion in neoTx DBA/2 mice but remain unaffected
in the neoTx BALB/c mice. This effect is also seen when the
results are converted to absolute numbers: although thymec-
tomized mice generally have two- to threefold lower numbers
of T cells, the increases in percentages ofcertain V(3expressing
T cells with self-reactive receptors are at least as high and
often higher (data not shown). While the increases are always
small, they were consistently observed in >100 thymec-
tomized mice investigated over a period of 1 yr. In contrast,
V03-bearing T cells, which are deleted in normal mice of
both strains because of Mls-2a expression, remain undetected
in thymectomized mice of either strain. The rescue of dele-
tion ofV)35 and V011 appeared to be strain dependent. There
was no significant increase in the percentage ofV05+ T cells
in the neoTx BALB/c mice, whereas the same treatment of
DBA/2 mice always significantly increased the number of
V05-expressing T cells. Conversely, the number of V011+
T cells was always enhanced in BALB/c mice, but not affected
in DBA/2 mice. As an additional control, mice were alsoSham
Vp6 U
ap-TCR
￿
ap-TCR
Figure 1.
￿
Two-parameterflow cytometryanalysis ofcell surface expres-
sion oftheindicatedV(3vs. CD4 on T cell-enrichedLN cells from sham
or thymectomized mice in BALB/c (A) or DBA/2 (B) mice. Mice were
thymectomized3dafterbirth.Peripheral Tcells were analyzedwhen mice
were 2-3 mo old. Percentages for TCR expression are givenin Table 1.
analyzed for VS14 expression. While expression of T cells
with a V014 TCR is variable and dependent on the presence
of certain positive selecting elements (27), no self-antigen has
been defined that results in elimination of Vfl14+ cells.
NeoTx B Sham NeoTx
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VS expression wasdetermined by immunofluorescent staining with the
anti-VO mAbs described in Material and Methods. Analysis wasperformed
on T cell-enriched LN cells from 2-3-mo-old sham or thymectomized
mice. Values indicated are percentage of TCR-a/o+ LN cells and are
reported as the mean t SE from three separate experiments.
Clearly, the number of Vf14-expressing T cells in the pe-
riphery was not enhanced as a result of thymectomy. The
decrease in Vfl4+ T cells sometimes observed in neoTx
DBA/2 mice is possibly a consequence of the increase in T
cells with self-reactive receptors. It is interesting to note that
both in the BALB/c and DBA/2 strains, the majority of T
cells that escape deletion are in the CD8+ subset (Fig. 1).
In conclusion, the absence of a thymus results in the appear-
ance oflowbut significant T cells with autoreactive receptors
in thymectomized mice, which is consistent with earlier reports
in nude mice (12, 13).
T Cells That Escape Clonal Deletion Are Not Functional.
neoTx mice develop organ-localized autoimmune diseases,
provided the thymectomy is performed between days 1 and
4 after birth; yet, not all strains are equally susceptible to
this phenomenon (16). In the A/J mouse strain (H-2'), 90%
offemale mice develop o6phoritis, and 30% ofBALB/c mice
(H-2d) develop gastritis. In sharp contrast, thymectomized
DBA/2 mice (also H-2d) do not develop any known autoim-
mune disorders. Since in both DBA/2 and BALB/c mice
thymectomy results in a failure ofclonal deletion (see above),
it appears that factors other than MHC determine whether
such potentially autoreactive cells are indeed harmful. We
therefore tested the hypothesis that autoimmune diseases are
related to the presence of the "forbidden" T cell clones that
had escaped deletion in the thymus by analyzing peripheral
VS6+ and V#11+ T cells from thymectomized mice for
their functional capabilities. This analysis is particularly rele-
vant in view of the recentfinding that, even when V06- and
V011-expressing T cells are of the CD8+ phenotype, they
may still display Mls-la (references 29 and 30, for V#6 cells)
or I-E (reference 31, for VS11 cells) reactivity.
We first tested whether neoTx mice are capable of gener-
ating normal T cell responses to antireceptor antibodies. In
thymectomized DBA/2 mice, stimulationbyantiVS8.2 TCR
mAb was used as a control, since V#8.2+ T cells are not
deleted in DBA/2 mice. Indeed, T cells from normal and
thymectomized mice responded equally well to antiV08.2
mAb stimulation, demonstrating that T cellsfrom neoTxmice
are functional (Fig. 2 A). For the BALB/c strain, stimulation
with antiV06 mAb was used as a control, since no known
deletional elements affecting the level of V06+ T cells are
expressed in BALB/c. The results demonstrate that also in
this control, responsiveness was unaffected by thymectomy
(Fig. 3 B). As an additional control, T cells from DBA/2
and BALB/c mice were stimulated with anti-pan TCRcx/a
mAb (21); this mAb reacts with all TCRci/0-expressing
T cells, regardless of the typeof0 chain used. Again, T cells
isolated from thymectomized mice responded equally well
as T cells from normal mice (Fig. 3A for BALB/c; data not
shown for DBA/2). Taken together, these findings establish
that neonatal thymectomy does not result in a generalized
defect in T cell function.
In contrast, although T cells expressing V#6 (in DBA/2
mice) and V011 (in BALB/c) were found in the periphery
of thymectomized mice, such cells were not responsive to
stimulation over a wide range of specific mAb concentrations
(Figs. 2 B and 3 C), even in the presence of I11r2. This defect
Table 1. V,B Expression in neoTx Mice
BALB/c DBA/2
Sham neoTx Sham neoTx
V03 0.1 ± 0.03 0.7 ± 0.19 0.2 ± 0.04 0.2 ± 0.21
V05 0.1 ± 0.03 0.3 t 0.12 0.8 ± 0.12 2.6 ± 1.14
V06 11.8 ± 0.08 11 .9 t 0.19 0.1 t 0.05 2.1 ± 0.28
V#11 1.0 ± 0.11 3.7 ± 0.54 2.1±0.24 2.7±1.85
VS14 8.2 ± 0.09 8.4 ± 0.59 10.2 ± 0.52 7.6 ± 1.34Figure 2.
￿
T cells that escape clonal deletionare not functional. T cell-en-
riched spleen cells from 2-3-mo-old sham or thymectomizedDBA/2 mice
were stimulated with antiV/3 8.2 (A) or antiV06 (B) mAb at the indi-
cated concentration. rlIr2 was added at a final concentration of 10 U/ml.
is not due to a failure of CD8+ T cells to respond in such
assays, as previous studies (26, 32) demonstrated that TCR
occupancy and cross-linking are sufficient to induce prolifer-
ation in CD8+ T cells, provided an exogenous source of
lymphokines is added. To demonstrate that the antiVo11 mAb
could effectively activate T cells from normal mice, T cells
from C57B1/6 mice that lack expression of I-E and therefore
do not delete V011+ T cells in the thymus were tested as
well. It can be seen that the Va11+ T cells from this non-
deleting strain of mice responded in a dose-dependent fashion
to specific stimulation (Fig. 3 C). Similarly, the antiV/36 mAVs
ability to activate T cells from normal mice was demonstrated
for BALB/c mice (Fig. 3 B). Thus, neonatal thymectomy has
resulted in a specific nonresponsiveness of those peripheral
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Figure 3.
￿
T cells that escape clonal deletion are notfunctional. T cell-en-
riched spleen cells from 2-3-mo-old sham or day 3 thymectomizedBALB/c
mice or control C57B1/6 mice were stimulated with anti-a/S (A), anti-
V/36 (B), or antiVoll (C) mAb at the indicated concentration. rII.2 was
added at a final concentration of 10 U/ml.
T cells (shown here for spleen cells; identical findings were
obtained with LN cells, data not shown) which in normal
mice are subject to intrathymic clonal deletion, whileleaving
responsiveness ofother T cells subsets intact. With the caveat
that the in vivo behavior of these cells might be different,
it would therefore appear that the development of autoim-
mune diseases in neoTx mice is unlikely to be related to the
failure ofclonal deletion, since clonal unresponsiveness in the
"forbidden" T cells would preclude any harmful effects.
Finally, we tested to which extent the observed unrespon-
siveness was due to a failure inlymphokine production. Under
conditions of antigen presentation by defective APC, T cell
clones can be made unresponsive to activationby their specific
ligand (33). The lack of responsiveness is due to an inabilityto produce IJ,2 and can be overcome by the addition of the
lymphokine to the cultures (33). In ne6Tk mice, however,
the nonresponsiveness demonstrated by V011+ and V06+
in DBA/2 T cells could not be restored by the addition of
either rIL2 (Figs. 2 B and 3 C) or supernatants from Con
A-activated T cells (data not shown) to the cultures. In addi-
tion, the dysfunctional T cells failed to produce detectable
levels of lymphokines, whereas T cells that did respond to
mAb stimulation by proliferation also produced lymphokines
(Fig. 4).
DRA/2 V#6+ T Cellsfrom neoTx Mice Do Not Respond
to Syngeneic Spleen Cells. V06' T cells are deleted in mouse
strains in which Mls-la is expressed, and responding T cells
in anti-Mls-la MLCs predominantly utilize V(36+ TCRs,
indicating preferential reactivity of V06 for the Mls-la gene
product (3). We therefore used syngeneic, Mls-la' spleen
cells as stimulator cells for examination ofthe functional status
of the "forbidden" Va6+ T cells derived from thymec-
tomized DBA/2 mice. As shown in Fig. 5, T cellsfrom con-
trol and thymectomized DBA/2 mice do not respond to syn-
geneic stimulator cells, while both populations responded to
stimulator cells expressing allogeneic MHC antigens. The
efficacy of the DBA/2 stimulator cellswas demonstrated by
their ability to generate proliferative responses in allogeneic
C57B1/6 responder cells as well as in Mls-la-specific T cell
hybridomas (data not shown). These results extend the mAb
stimulation experiments, and demonstrate that the V#6+ T
cells remain tolerant to self-antigens expressed by syngeneic
spleen cells.
Figure 4.
￿
T cells that escape clonal deletion do not produce 11:.2. T
cell-enriched spleen cells from 2-3-mo-old sham or thymectomized BALB/c
mice were stimulated for 48 h with antiVli mAbs at doses of0.5, 5, and
50 Ftg/ml. Supernatants were harvested from the cultures and assayed for
lymphokine production by testing their ability to support proliferation
ofthe CTLL cell line at different dilutions. Only data for the highest con-
centration ofantiVo (50 tig/ml) and supernatant (50%) are given; anti-
Vo11-induced activation did not generate responses at any of the doses
tested.
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Figure 5.
￿
V06+ T cells from thymectomized DBA/2 mice do not re-
spond to autologous spleen cells. T cell-enriched spleen cells from 2-3-
mo-old sham (A) or thymectomized (B) DBA/2 mice were stimulated
with DBA/2 or C57BL/6 irradiated spleen cells.
BALB/c Animals Thymectomized on Day S or 8 Also Have
Increased Levels of V011-expressing T Cells. As mentioned
above, neonatal thymectomy may or may not result in the
development of autoimmune diseases, dependent upon the
strain of mice (16). Development of disease does not appear
to be correlated with the failure ofclonal deletion since both
BALB/c mice, which do develop disease, and DBA/2 mice,
which do not exhibit autoimmune diseases, fail to delete T
cells with "forbidden" Vos. This issue was additionally ad-
dressed by examining the T cell repertoire of mice thymec-
tomized afterday 4. It was previously reported that the timing
of the thymectomy is critical in inducing autoimmune dis-
eases. Mice thymectomized between days 1-4 may develop
disease whereas those thymectomized later do not develop
disease, even in strains extremely prone to neonatal thymec-
tomy-induced autoimmunedisease, such as A/J in which 90%
develop o6phoritis (16). As shown in Table 2, the T cell reper-
toire in BALB/c mice thymectomized on day 5 or 8is similar
to that ofmice thymectomized on day 3: the percentage of
V011' T cells is higher as compared with controls; the
significance of the slightly higher V011 values in the day 5/8-
ectornized vs. day 3-thymectomized mice cannot be evalu-
ated, since much fewer mice were tested in theformer group.
tTogether with the finding (see above) of unresponsiveness
in anti VSll proliferation assays, the presence of V011+ T
cells in mice that do not develop disease suggests that these
"forbidden" clones are not involved in induction of autoim-
munity.
The Early Postnatal Thymus Contains Functional T Cells with
"Forbidden" Receptors. We next addressed the possible origin
of the T cell clones that failed to be clonally deleted in the
periphery of neoTx mice. Self-reactive T cells can persist in
the neonatal thymus; in the DBA/2 strain of mice, mature
T cells expressing V(36 can be detected in the thymus as late
as 7-8 d afterbirth (reference 34; and our unpublished results).
"Forbidden" T cell clones in neoTx mice might be derived
from such early thymocytes with self-reactive receptors that
may escape from the neonatal thymus before thymectomy
is performed. We therefore examined the functional status
of the mature V06+ thymocytes in newborn DBA/2 and
(DBA/2 x C57B1/6) F1 mice. Approximately 3% Va6+
T cells can be detected by flow cytometry among the TCR-
cx/expressing single positive thymocytes in 4-5-d-old mice
of these strains (reference 34; and data not shown); in con-
trast, <0.5% V06+ T cells can be detected in the thymus
of adult mice of these strains. Surprisingly, these early post-
natal thymocytes responded to stimulation by cross-linked
antiV06 mAb both with and without the addition of rIIr2
to the cultures (Fig. 6 A ; and data not shown). Also, anti-
V06 mAb induced lymphokine production, as measured in
a CTLL proliferation assay, in neonatal but not inadult thymo-
cytes (Fig. 6 B). The CTLL assay may be somewhat more
sensitive than the proliferation assay, since neonatal thymo-
cytes consistently generated lymphokine production (Fig. 6
B) but not proliferation (Fig. 6 A) at low antiV/36 mAb doses.
Thus, the "forbidden" T cells in the neonatal thymus have
not yet been functionally inactivated. Since the T cell clones
with autoreactive receptors in the periphery of neoTx mice
are most likely derived from the neonatal thymus, anergy must
have been induced extrathymically.
VS expression was determined by immunofluorescent staining with the
anti-V# mAbs described in Material and Methods. Analysis was done
on T cell-enriched LN cells from 2-3 mo-old BALB/c mice thymecto-
mized on day 5 or 8 after birth. Control mice were littermates sham-
thymectomized at the same time. Values indicated are percentages of
TCR-a/S+ LN cells and are reported as the mean ± SE of three
separate experiments (for the sham- and day 5-thymectomized group)
or as individual values from two separate experiments (for the day
8-thymectomized group).
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Figure 6.
￿
V06+ T cells from neonatal mice are functional. Mature
single positive thymorytes from 4-5-d-oldhydrocortisone-treated DBA/2
or (C57BL/6 x DBt1/2)F1mice and6-wk-old adulthydrocortisone-treated
DBA/2 mice were stimulated with antiV06 mAb at the indicated con-
centrations. Cells were analyzed fortheirability to proliferate as measured
by [3H]TdRincorporation in thepresence of rl1r2 at 10 U/ml (A). Cul-
ture supernatants were tested at 50, 25, 12.5, and6.25% for theirability
to support proliferation of CTLL cells (B). Only results for the highest
concentration of supernatant are shown, since further dilution did not
result in responsiveness of the adult DBA/2 thymocytes.
Discussion
Clonal deletion originating in the thymus represents a major
mechanism for maintaining tolerance for self-antigens. At the
same time, it appears that effective alternative modes of toler-
ance acquisition exist (7-11). The present study defines a system
of apparent failed clonal deletion of potentially autoreactive
cells: in neoTxmice, T cells with certain self-reactive receptors
can be easily visualized; yet, thymectomy does not preclude
clonal inactivation of these T cells. Since it is likely that also
in normal physiological situations clonal deletion may often
Table 2. V,6 Expression in neoTx BALBA Mice
Sham Day 5 Day 8
V06
V011
11.6±0.2 11 .5±2 .9
1.6±0.2 7.3±2.5
12.0, 10.7
6.8, 3.2fail, e.g., when the required interactions between developing
T cellswith self-reactive receptors and hematopoietic elements
in the thymus do not occur, it is particularly relevant that
nonreactivity to self-antigens is still ensured through induc-
tion of clonal nonresponsiveness in T cellswith self-reactive
receptors.
The present studies also reexamine the stage of develop-
ment at which clonal deletion ofT cells occurs. We observed
the presence of T cells with self-reactive V(66 receptors in
the thymus during the first week after birth, in agreement
with earlier reports (34), and also found these cells to be func-
tional by the criteria of receptor-induced proliferation and
lymphokine production. Presumably, inefficient intrathymic
Mls-1a presentation in the early neonatal thymus is in part
responsible for the failed clonal deletion observed during this
phase. Their disappearance from the thymus within the first
10 d after birth is consistent with migration (34), and may
be additionally affected by clonal deletion at the single posi-
tive stage, consistent with recent results in TCR-transgenic
mice (35). These findings demonstrate that single positive
T cells with mature T cell characteristics, but self-reactive
receptors, are generated in the thymus. Theirpresence in pe-
ripheral lymphoid organs of neoTx mice suggests such cells
are allowed to migrate, despite theirpotentially harmful effects
(reference 14; and present results) . Together, these data ex-
pand on the initial clonal deletion studies which appeared
to indicate that clonal deletion was completed at the double
positive stage of T cell development in the thymus: elimina-
tion ofT cellswith autoreactive receptors was evident among
all peripheral T cells and TCR-a/0-expressing single posi-
tive thymocytes, but only partially among the DP thymo-
cytes (1-4), implying that deletion occurred before transi-
tion to the single positive stage. Further support for this
concept has been obtained, including the observations that
blocking of CD4 prevents deletion of V017a and V)311 in
the CD8 subset of thymocytes (36-38), and that in TCIt
transgenic mice, CD4+ CD8+ thymocytes with self-reactive
receptors are deleted (6, 39). It now appears that tolerance
induction in fact occurs over a longer period of time during
T cell development; the particular timeofoccurrence is likely
to reflect differences in affinity of the receptor for the partic-
ular self-antigens and their site and level ofexpression, rather
than receptor density and developmental stage of the differen-
tiating thymocytes (35). Definition of the complexities of
the clonal deletion phenomenon is particularly relevant if the
molecular events accompanying this process are to be identified;
rather than expecting deletion to be manifested at a discrete
stage ofT cell development, a much broader phaseof devel-
opment may need to be analyzed.
Clonal anergy was reported to represent an alternative
pathway for acquisition of nonreactivity to self-antigens in
several other systems (7-11), and shown to occurboth inside
and outside the thymus. Whether peripheral induction of
clonal anergy is thymus dependent was not previously ad-
dressed, but the present studies indicate it is not: after thymec-
tomy is performed on day 3 after birth, clonal anergy is
nevertheless established in the peripheral T cell repertoire.
We cannot rule out that thymic cells crucial for tolerance
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induction have migrated to the periphery before thymectomy,
but would contend that such "escaped" thymic cells appar-
ently occur in sufficient amounts to cause clonal anergy but
not clonal deletion. It should be noted, however, that the
ability to induce tolerance is not a property confined to thymic
elements: allogeneic splenic dendritic cells, when added to
fetal thymic organ cultures, can induce specific tolerance in
the developing thymocytes (40), although the mechanism in
this setting was not defined. Postthymectomy-induced toler-
ance induction may therefore indeed reflect a thymus-
independent phenomenon. At face value, these results are at
variance with our earlier report on specific enterotoxin re-
sponsiveness ofT cells with potentially self-reactive receptors
generated in nude mice (13), suggesting that clonal anergy
is not generated in this model of failed clonal deletion.
However, more recent studies show that also in nude mice,
responsiveness ofT cells with "forbidden" receptors to cross-
linked anti TCR antibodies cannot be obtained, while en-
terotoxin responsiveness may sometimes be intact (data not
shown) .
In the mouse strains tested here, neonatal thymectomy ap-
pears to affect T cells with certain self-reactive receptors more
than others. This differential impact of thymectomy in different
strains may well be related to the extent of deletion accom-
plished at the time of thymectomy: when intrathymic dele-
tion of T cells expressing a particular V(3 is complete by 3 d
after birth, thymectomy would not result in any appearance
of "forbidden" clones in the periphery. Our results therefore
predict that deletion of V#3+ T cells, but not Vf6 + and
V011+ T cells, is accomplished before day 3 of neonatal life.
Consistent with this prediction, a recent study (41) reported
the complete absence of V03+ T cells in the day 4 neonatal
thymus of Mls-1a mice on a BALB background, while
V06+ and V011+ T cells persisted in the thymus for 10-14 d
after birth (41).
In view of the finding that peripheral T cells with poten-
tially self-reactive receptors in neoTx mice are not functional
by the criteria ofin vitroactivation, the question arises whether
such T cells are involved in the pathogenesis of the autoim-
mune diseases observed in such mice (15, 16). Arguments
against this concept can be raised on the basis ofthe observa-
tion that T cells with potentially self-reactive Vf6 and V011
receptors appear not only in mouse strains susceptible to au-
toimmune diseases following thymectomy (reference 14;
present study), but also, as shown here, in non-autoimmune
strains and in mice thymectomized at later times after birth
(a condition not generating autoimmune diseases; see 15, 16).
We therefore consider it unlikely that the autoimmune defects
observed in thymectomized mice are due to direct patholog-
ical effects of T cells with V06 and V011 receptors. Several
alternative hypotheses can be considered to explain the devel-
opment of autoimmunity in certain mouse strains after
thymectomy. First, a failure in clonal deletion may merely
reflect only one of the consequences ofneonatal thymectomy,
and development of autoimmunity may be unrelated to this
event. A second more conservative hypothesis relies on the
presumption that failed clonal deletion is a primary event in
the generation of autoimmunity: since the present analysisis
limited to those T cells whose receptor specificity can be
identified
by flow cytometry analysis, it is entirely possible
that
other self-reactive T cells, not detected with the present
technology,
also escape clonal deletionbut fail to be inacti-
vated
for the pertinent antigens incertain mouse strains
.
The
difference
in susceptibility to development ofautoimmunity
in
different mouse strains would then be related to the level
and
time of exposure to those self-antigens for which toler-
ance
is tobe acquired
.
This hypothesis is consistent with ear-
lier
observations (42-44) that autoimmunity can be trans-
ferred
with peripheral T cells from thymectomized mice, and
that
the efficacy ofsuch transfers is dependent on the strain
and
age of the recipients
.
Third, since suppressor cells that
can
prevent such transfers of autoimmunity have been postu-
lated
(42-44), the strain-independent outcome of the conse-
quences
ofthymectomy may reflect the extent to which such
regulatory
cellsare generated and then operate toprevent the
harmful
effects of T cells with self-reactive receptors
.
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